Metropolis Healthcare Limited (NSE:METROPOLIS)

Metropolis Healthcare Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	119,286	89,980	80,210	88,295	63,926	104,174
Market Cap Growth	14.83%	12.18%	-9.16%	38.12%	-38.64%	-9.07%
Enterprise Value	118,607	91,299	80,294	89,560	65,626	99,827
Last Close Price	581.25	433.14	389.56	429.16	310.04	502.62

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	53.08	47.35	55.33	69.08	44.74	48.64
Forward PE	41.61	37.34	38.80	51.55	36.66	43.71
PS Ratio	6.69	5.47	6.03	7.31	5.57	8.48
PB Ratio	7.22	5.90	6.01	8.03	6.45	11.73
P/TBV Ratio	26.09	27.94	32.80	34.61	40.28	148.36
P/FCF Ratio	29.08	29.29	36.57	44.08	32.87	46.80
P/OCF Ratio	26.85	25.66	30.53	33.44	25.87	41.13
PEG Ratio	1.65	1.40	1.94	2.43	11.11	2.47

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.65	5.55	6.03	7.42	5.72	8.13
EV/EBITDA Ratio	33.92	30.71	37.39	41.16	27.86	32.55
EV/EBIT Ratio	37.29	34.09	41.32	45.90	32.22	35.44
EV/FCF Ratio	28.91	29.72	36.61	44.71	33.75	44.84

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.16	0.15	0.15	0.18	0.27	0.43
Debt / EBITDA Ratio	0.77	0.61	0.72	0.70	0.94	1.12
Debt / FCF Ratio	0.65	0.76	0.93	0.98	1.37	1.70
Net Debt / Equity Ratio	-0.05	0.02	0.06	0.07	0.19	0.22
Net Debt / EBITDA Ratio	-0.23	0.10	0.40	0.33	0.78	0.65
Net Debt / FCF Ratio	-0.19	0.09	0.39	0.36	0.95	0.89
Asset Turnover	0.82	0.82	0.78	0.79	0.76	0.97
Inventory Turnover	8.24	7.99	7.00	6.48	5.73	6.49
Quick Ratio	1.43	1.12	0.91	1.02	0.79	1.07
Current Ratio	1.71	1.40	1.18	1.29	1.14	1.30
Return on Equity (ROE)	14.56%	13.37%	11.96%	12.29%	15.26%	26.90%
Return on Assets (ROA)	9.17%	8.36%	7.10%	7.98%	8.40%	13.89%
Return on Invested Capital (ROIC)	14.93%	13.29%	11.43%	12.23%	13.78%	27.74%
Return on Capital Employed (ROCE)	16.10%	14.80%	12.40%	14.90%	16.50%	22.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.88%	2.11%	1.81%	1.45%	2.23%	2.06%
FCF Yield	3.44%	3.41%	2.73%	2.27%	3.04%	2.14%
Dividend Yield	0.35%	0.46%	-	0.23%	0.64%	0.39%
Payout Ratio	18.49%	10.91%	-	16.04%	28.67%	19.11%
Buyback Yield / Dilution	-0.03%	0.12%	-0.69%	-0.05%	0.09%	-0.49%
Total Shareholder Return	0.31%	0.58%	-0.69%	0.18%	0.73%	-0.10%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error